Using a murine myocardial infarction model, the nanoparticles were injected into the peri-infarct region where the VEGF promoted revascularization of ischemic myocardium, reduced the size of infarct and improved left ventricular contractility. This evidence concerns the gene VEGFA and myocardial infarction.